The Shifting Paradigm of Atopic Dermatitis - Part 1
This content is being presented as a live webinar broadcast. If you have participated in the live activity, please continue to the post test. If you have not participated in the live activity, please check back soon for the enduring materials to be posted.
Overview
This certified CME activity is designed for dermatologists, dermatology nurse practitioners and dermatology physician assistants involved in the management of atopic dermatitis.Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals Learning Objectives
Upon completion of this activity, the participant should be able to: - Identify the mechanisms of action, efficacy, and safety of emerging targeted therapies for AD.
- Recognize the lifestyle measures and daily skin care practices that are the foundation of AD treatment plans.
- Discuss the prevalence, presentation, and quality-of-life effects of AD in adults.
- Interpret and explain the recognized and emerging comorbidities associated with AD in children, adolescents, and adults.
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation Statement Evolve Medical Education LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
The following faculty members have the following financial relationships with commercial interests: Peter Lio, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Exeltis USA Dermatology, LLC; Galderma Laboratories L.P.; Johnson & Johnson; La Roche Posay; Pfizer Inc; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme; and Valeant Pharmaceuticals International, Inc. Grant/Research Support: AO Biome and La Fondation pour la Dermatite Atopique Robert Sidbury, MD has had no financial agreements or affiliations during the past year. Editorial Support Disclosure Kristin Richardson, Writer and Cheryl Cavanaugh, MS, Evolve Medical Education LLC have no real or apparent conflicts of interest to report. Rishi P. Singh, MD, Peer Reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Allergan Inc.; Carl Zeiss Meditec; Genentech, Inc; Optos; Regeneron Pharmaceuticals, Inc; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!